These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10430149)

  • 1. Safety and efficacy of a new oral contrast agent for sonography: a phase II trial.
    Lev-Toaff AS; Langer JE; Rubin DL; Zelch JV; Chong WK; Barone AE; Goldberg BB
    AJR Am J Roentgenol; 1999 Aug; 173(2):431-6. PubMed ID: 10430149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2 oral ultrasonography contrast agents: simethicone-coated cellulose and simethicone-water rotation in improving pancreatic visualization.
    Ishigami K; Abu-Yousef DM; Kao SC; Abu-Yousef MM
    Ultrasound Q; 2014 Jun; 30(2):135-8. PubMed ID: 24850028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain.
    Bree RL; Arnold RJ; Pettit KG; Kaniecki DJ; O'haeri C; LaFrance ND; Toaff AL
    Acad Radiol; 2001 Mar; 8(3):234-42. PubMed ID: 11249087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT.
    Sahani DV; Jhaveri KS; D'souza RV; Varghese JC; Halpern E; Harisinghani MG; Hahn PF; Saini S
    Acad Radiol; 2003 May; 10(5):491-6. PubMed ID: 12755536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of simethicone coated cellulose (SonoRx) as a negative oral contrast agent for abdominal-pelvic computed tomography.
    Saini S; Jhaveri KS; Sahani DV; Varghese JC; Hahn PF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S357-8. PubMed ID: 12188274
    [No Abstract]   [Full Text] [Related]  

  • 7. Simethicone coated cellulose as an oral contrast agent for ultrasound of the upper abdomen.
    Harisinghani MG; Saini S; Schima W; McNicholas M; Mueller PR
    Clin Radiol; 1997 Mar; 52(3):224-6. PubMed ID: 9091258
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors Predictive of Improved Abdominal Ultrasound Visualization after Oral Administration of Simethicone.
    Marsico M; Gabbani T; Casseri T; Biagini MR
    Ultrasound Med Biol; 2016 Nov; 42(11):2532-2537. PubMed ID: 27481017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety.
    Leander P; Golman K; Månsson S; Höglund P
    Invest Radiol; 2010 Sep; 45(9):559-64. PubMed ID: 20644487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cellulose concentration on the efficacy of a cellulose-based oral contrast agent for gastrointestinal ultrasonography.
    Sisler WJ; Tilcock C
    J Ultrasound Med; 1995 Apr; 14(4):267-72. PubMed ID: 7602683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound contrast. Oral and i.v. agents amplify the image.
    Barr RG
    Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved retroperitoneal and gastrointestinal sonography using oral contrast agents in a porcine model.
    Muradali D; Burns PN; Pron G; Hope-Simpson D; Wilson S
    AJR Am J Roentgenol; 1998 Aug; 171(2):475-81. PubMed ID: 9694479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis.
    Small WC; DeSimone-Macchi D; Parker JR; Sukerkar A; Hahn PF; Rubin DL; Zelch JV; Kuhlman JE; Outwater EK; Weinreb JC; Brown JJ; de Lange EE; Woodward PJ; Arildsen R; Foster GS; Runge VM; Aisen AM; Muroff LR; Thoeni RF; Parisky YR; Tanenbaum LN; Totterman S; Herfkens RJ; Knudsen J; Bernardino ME
    J Magn Reson Imaging; 1999 Jul; 10(1):15-24. PubMed ID: 10398973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial.
    Mattrey RF; Trambert MA; Brown JJ; Young SW; Bruneton JN; Wesbey GE; Balsara ZN
    Radiology; 1994 Jun; 191(3):841-8. PubMed ID: 8184076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellulose as a gastrointestinal US contrast agent.
    Lund PJ; Fritz TA; Unger EC; Hunt RK; Fuller E
    Radiology; 1992 Dec; 185(3):783-8. PubMed ID: 1438763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system.
    Gutierrez JE; Rosenberg M; Duhaney M; Simon JA; Brueggenwerth G; Agris JM; Knopp EA
    J Magn Reson Imaging; 2015 Mar; 41(3):788-96. PubMed ID: 24578298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
    Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
    Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an oral contrast agent for sonography: clinical and economic considerations.
    LaFrance ND; Yin D; Brooks K; Lev-Toaff AS; Bensel KS; Meeks MJ; Macchi D
    Acad Radiol; 1996 Apr; 3 Suppl 1():S160-1. PubMed ID: 8796551
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved image quality during abdominal ultrasonography by clebopride + simethicone.
    Varas MJ; López A
    Methods Find Exp Clin Pharmacol; 1991; 13(1):69-72. PubMed ID: 1870360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.